An atypical clostridium strain related to the clostridium botulinum group iii strain isolated from a human blood culture

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 339-343

  Bouvet, Philippe ^a   Ruimy, Raymond ^b   Bouchier, Christiane ^a   Faucher, Nathalie ^c   Mazuet, Christelle ^a   Popoff, Michel R ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CEFOTAXIME; METRONIDAZOLE;

AGED; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOASSAY; BLOOD CULTURE; CASE REPORT; CLOSTRIDIUM BOTULINUM; CTP GENE; DEATH; DNAK GENE; FEMALE; FEMUR FRACTURE; FRANCE; GAS CHROMATOGRAPHY; GLPK GENE; GYRA GENE; HOUSEKEEPING GENE; HUMAN; MENTAL DISEASE; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA SEQUENCE; RPOB GENE; SEPSIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; THERAPY DELAY; VERY ELDERLY; WEAKNESS;

AGED, 80 AND OVER; BACTERIAL PROTEINS; BLOOD; CLOSTRIDIUM BOTULINUM TYPE C; CLOSTRIDIUM BOTULINUM TYPE D; CLUSTER ANALYSIS; DNA, BACTERIAL; DNA, RIBOSOMAL; FATAL OUTCOME; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEPSIS; SEQUENCE ANALYSIS, DNA;

EID: 84891526262     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00390-13     Document Type: Article

References (38)

1. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. 2002. Anaerobic bacteriology manual, 6th ed. Star Publishing Company, Belmont, CA.
2. Carlier JP. 2002. The metabolic end-products-A rapid identification tool for common anaerobic bacteria isolated in clinical microbiology. Recent Res. Dev. Microbiol. 6:157-175.
3. Lindström M, Korkeala H. 2006. Laboratory diagnosis of botulism. Clin. Microbiol. Rev. 19:298-314. http://dx.doi.org/10.1128/CMR.19.2.298-314. 2006.
4. Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, Chenal A, Geny B, Vandewalle A, Popoff MR. 2010. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon 55:61-72. http://dx.doi.org/10.1016/j. toxicon.2009.06.037.
5. Carlier JP, K'Ouas G, Bonne I, Lozniewski A, Mory F. 2004. Oribacterium sinus gen. nov., sp. nov., within the family 'Lachnospiraceae' (phylum Firmicutes). Int. J. Syst. Evol. Microbiol. 54:1611-1615. http://dx.doi.org/10. 1099/ijs.0.63060-0.
6. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402. http://dx.doi.org/10.1093/nar/ 25.17.3389.
7. Sasaki Y, Kojima A, Aoki H, Ogikubo Y, Takikawa N, Tamura Y. 2002. Phylogenetic analysis and PCR detection of Clostridium chauvoei, Clostridium haemolyticum, Clostridium novyi types A and B, and Clostridium septicum based on the flagellin gene. Vet. Microbiol. 86:257-267. http://dx.doi.org/10.1016/ S0378-1135(02)00002-0.
8. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
9. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
10. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120. http://dx.doi.org/10.1007/BF01731581.
11. Kumar S, Tamura K, Jakobsen IB, Nei M. 2001. MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245. http://dx.doi.org/10.1093/bioinformatics/17.12.1244.
12. Collins MD, East AK. 1998. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J. Appl. Microbiol. 84:5-17. http://dx.doi.org/10.1046/j.1365-2672.1997.00313.x.
13. Alouf JE. 2000. Cholesterol-binding cytolytic protein toxins. Int. J. Med. Microbiol. 290:351-356. http://dx.doi.org/10.1016/S1438-4221(00)80039-9.
14. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA. 1994. The phylogeny of the genus Clostridium: Proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-826. http://dx.doi.org/10.1099/00207713-44-4- 812.
15. Nakamura K, Kohda T, Umeda K, Yamamoto H, Mukamoto M, Kozaki S. 2010. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Vet. Microbiol. 140:147-154. http://dx.doi.org/10.1016/j.vetmic.2009.07.023.
16. Skarin H, Hafstrom T, Westerberg J, Segerman B. 2011. Clostridium botulinum group III: A group with dual identity shaped by plasmids, phages and mobile elements.BMCGenomics 12:185. http://dx.doi.org/10.1186/1471-2164-12-185.
17. Fatmawati NN, Sakaguchi Y, Suzuki T, Oda M, Shimizu K, Yamamoto Y, Sakurai J, Matsushita O, Oguma K. 2013. Phospholipase C produced by Clostridium botulinum types C and D: Comparison of gene, enzymatic, and biological activities with those of Clostridium perfringens alpha-toxin. Acta Med. Okayama 67:9-18. http://escholarship.lib.okayama-u.ac.jp/amo/.
18. Popoff MR, Hauser D, Boquet P, Eklund MW, Gill DM. 1991. Characterization of the C3 gene of Clostridium botulinum types C andDand its expression in Escherichia coli. Infect. Immun. 59:3673-3679.
19. Gonzalez DJ, Lee SW, Hensler ME, Markley AL, Dahesh S, Mitchell DA, Bandeira N, Nizet V, Dixon JE, Dorrestein PC. 2010. Clostridiolysin S, a post-translationally modified biotoxin from Clostridium botulinum. J. Biol. Chem. 285:28220-28228. http://dx.doi.org/10.1074/jbc .M110.118554.
20. Brook I. 2010. The role of anaerobic bacteria in bacteremia. Anaerobe 16:183-189. http://dx.doi.org/10.1016/j.anaerobe.2009.12.001.
21. Rechner PM, Agger WA, Mruz K, Cogbill TH. 2001. Clinical features of clostridial bacteremia: A review from a rural area. Clin. Infect. Dis. 33:349-353. http://dx.doi.org/10.1086/321883.
22. Abdulla A, Yee L. 2000. The clinical spectrum of Clostridium sordellii bacteraemia: Two case reports and a review of the literature. J. Clin. Pathol. 53:709-712. http://dx.doi.org/10.1136/jcp.53.9.709.
23. Libby DB, Bearman G. 2009. Bacteremia due to Clostridium difficile-review of the literature. Int. J. Infect. Dis. 13:e305-e309. http://dx.doi.org/10. 1016/j.ijid.2009.01.014.
24. Hallit RR, Afridi M, Sison R, Salem E, Boghossian J, Slim J. 2013. Clostridium tetani bacteraemia. J. Med. Microbiol. 62:155-156. http://dx.doi.org/10.1099/jmm.0.044941-0.
25. Schade RP, Van Rijn M, Timmers HJ, Dofferhoff AS, Klaassen CH, Meis JF. 2006. Clostridium cadaveris bacteraemia: Two cases and review. Scand. J. Infect. Dis. 38:59-62. http://dx.doi.org/10.1080/00365540500388792.
26. Vanderhofstadt M, Andre M, Lonchay C, Levecque P, Holemans X, Canon JL, D'Hondt L. 2010. Clostridium tertium bacteremia: Contamination or true pathogen? A report of two cases and a review of the literature. Int. J. Infect. Dis. 14(Suppl 3):e335-e337.
27. Williams OM, Brazier J, Peraino V, Goldstein EJ. 2010. A review of three cases of Clostridium aldenense bacteremia. Anaerobe 16:475-477. http://dx.doi.org/10.1016/j.anaerobe.2010.08.004.
28. Poulain B, Popoff MR, Molgo J. 2008. How do the botulinum neurotoxins block neurotransmitter release: From botulism to the molecular mechanism of action. Botulinum J. 1:14-87. http://dx.doi.org/10.1504/TBJ.2008.018951.
29. Montecucco C, Rossetto O, Popoff MR. 2006. Neurotoxigenic clostridia, p 679-697. In Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (ed), The prokaryotes, vol 4. Springer, New York, NY.
30. Eklund MW, Poysky FT. 1974. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl. Microbiol. 27: 251-258.
31. Eklund MW, Poysky FT, Peterson ME, Meyers JA. 1976. Relationship of bacteriophage to alpha toxin production in Clostridium novyi types A and B. Infect. Immun. 14:798-803.
32. Eklund MW, Poysky FT, Reed SM, Smith CA. 1971. Bacteriophage and the toxigenicity of Clostridium botulinum type C. Science 172:480-482. http://dx.doi.org/10.1126/science.172.3982.480.
33. Sakaguchi Y, Hayashi T, Kurokawa K, Nakayama K, Oshima K, Fujinaga Y, Ohnishi M, Ohtsubo E, Hattori M, Oguma K. 2005. The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny. Proc. Natl. Acad. Sci. U. S. A. 102:17472-17477. http://dx.doi.org/10.1073/pnas .0505503102.
34. Schallehn G, Eklund MW, Brandis H. 1980. Phage conversion of Clostridium novyi type A. Zentralbl. Bakteriol. 247:95-100.
35. Sakaguchi Y, Hayashi T, Yamamoto Y, Nakayama K, Zhang K, Ma S, Arimitsu H, Oguma K. 2009. Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C. J. Bacteriol. 191:3282-3291. http://dx.doi.org/10.1128/JB .01797-08.
36. Yamakawa K, Karasawa T, Kakinuma H, Maruyama H, Takahashi H, Nakamura S. 1997. Emergence of Clostridium botulinum type B-like nontoxigenic organisms in a patient with type B infant botulism. J. Clin. Microbiol. 35:2163-2164.
37. Oguma K, Yokota K, Hayashi S, Takeshi K, Kumagai M, Itoh N, Tachi N, Chiba S. 1990. Infant botulism due to Clostridium botulinum type C toxin. Lancet 336:1449-1450.
38. Skarin H, Segerman B. 2011. Horizontal gene transfer of toxin genes in Clostridium botulinum: Involvement of mobile elements and plasmids. Mob. Genet. Elements 1:213-215. http://dx.doi.org/10.4161/mge.1.3 .17617.